Manisha A. Narasimhan | Regeneron Pharmaceuticals, Inc. |
Leonard S. Schleifer | Regeneron Pharmaceuticals, Inc. |
George Damis Yancopoulos | Regeneron Pharmaceuticals, Inc. |
Marion McCourt | Regeneron Pharmaceuticals, Inc. |
Robert E. Landry | Regeneron Pharmaceuticals, Inc. |
Carter Gould | UBS Securities LLC |
Cory W. Kasimov | JPMorgan Securities LLC |
Christopher J. Raymond | Piper Jaffray & Co. |
Geoffrey C. Porges | Leerink Partners LLC |
Matthew Luchini | BMO Capital Markets (United States) |
Terence Flynn | Goldman Sachs & Co. LLC |
Ying Huang | Bank of America Merrill Lynch |
Welcome to the Regeneron Pharmaceuticals Q3 2018 Earnings Conference Call. My name is John and I'll be your operator for today's call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. Please note, the conference is being recorded.